Cargando…

Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures

Heat shock protein 90 (Hsp90) is a widely investigated target for anticancer therapy. The experimental Hsp90 inhibitors ICPD47 and ICPD62 demonstrated anticancer activity against colorectal, osteosarcoma and cervical cancer cell lines. However, their anticancer activity has not been investigated aga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daunys, Simonas, Matulis, Daumantas, Petrikaitė, Vilma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838130/ https://www.ncbi.nlm.nih.gov/pubmed/31700053 http://dx.doi.org/10.1038/s41598-019-52652-1

Ejemplares similares

Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90
por: Kazlauskas, Egidijus, et al.
Publicado: (2012)

Correction: Thermodynamics of Aryl-Dihydroxyphenyl-Thiadiazole Binding to Human Hsp90
por: Kazlauskas, Egidijus, et al.
Publicado: (2012)

Inhibition of Carbonic Anhydrase IX Suppresses Breast Cancer Cell Motility at the Single-Cell Level
por: Janoniene, Agne, et al.
Publicado: (2021)

Titration Calorimetry Standards and the Precision of Isothermal Titration Calorimetry Data
por: Baranauskienė, Lina, et al.
Publicado: (2009)

Intrinsic Solubility of Ionizable Compounds from pK(a) Shift
por: Preikša, Joku̅bas, et al.
Publicado: (2023)

Anticancer Activity of Sunitinib Analogues in Human Pancreatic Cancer Cell Cultures under Normoxia and Hypoxia
por: Skaraitė, Ieva, et al.
Publicado: (2023)

Measurement of Nanomolar Dissociation Constants by Titration Calorimetry and Thermal Shift Assay – Radicicol Binding to Hsp90 and Ethoxzolamide Binding to CAII
por: Zubrienė, Asta, et al.
Publicado: (2009)

New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples
por: Stravinskiene, Dovile, et al.
Publicado: (2019)

Co-Crystalization and In Vitro Biological Characterization of 5-Aryl-4-(5-Substituted-2-4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors
por: Sharp, Swee Y., et al.
Publicado: (2012)

Differences of statin activity in 2D and 3D pancreatic cancer cell cultures
por: Paškevičiūtė, Miglė, et al.
Publicado: (2017)

Relationship between Antioxidant and Anticancer Activity of Trihydroxyflavones
por: Grigalius, Ignas, et al.
Publicado: (2017)

The Potential of Dietary Antioxidants from a Series of Plant Extracts as Anticancer Agents against Melanoma, Glioblastoma, and Breast Cancer
por: Liaudanskas, Mindaugas, et al.
Publicado: (2021)

Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications
por: Ardestani, Mina, et al.
Publicado: (2022)

HSP-90 Inhibitor Ganetespib is Synergistic with Doxorubicin in Small Cell Lung Cancer
por: Lai, Chien-Hao, et al.
Publicado: (2013)

Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures
por: Čeponytė, Ugnė, et al.
Publicado: (2018)

Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
por: Yaglom, Julia A., et al.
Publicado: (2018)

Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent
por: Horibe, Tomohisa, et al.
Publicado: (2011)

An update on anticancer drug development and delivery targeting carbonic anhydrase IX
por: Kazokaitė, Justina, et al.
Publicado: (2017)

Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro
por: Epp-Ducharme, Brittany, et al.
Publicado: (2021)

HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy
por: Lin, Tzu-yin, et al.
Publicado: (2016)

Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
por: Proia, David A., et al.
Publicado: (2012)

Intrinsic thermodynamics of ethoxzolamide inhibitor binding to human carbonic anhydrase XIII
por: Baranauskienė, Lina, et al.
Publicado: (2012)

Phenolic Fractions from Vaccinium vitis-idaea L. and Their Antioxidant and Anticancer Activities Assessment
por: Vilkickyte, Gabriele, et al.
Publicado: (2020)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Proton Pump Inhibitors Modulate Transport Of Doxorubicin And Its Liposomal Form Into 2D And 3D Breast Cancer Cell Cultures
por: Paškevičiūtė, Miglė, et al.
Publicado: (2019)

Author Correction: Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
por: Yaglom, Julia A., et al.
Publicado: (2018)

Fractionation and Characterization of Triterpenoids from Vaccinium vitis-idaea L. Cuticular Waxes and Their Potential as Anticancer Agents
por: Vilkickyte, Gabriele, et al.
Publicado: (2023)

Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer
por: Hyun, Seung Yeob, et al.
Publicado: (2018)

Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors
por: Murillo-Solano, Claribel, et al.
Publicado: (2017)

Thiazide and other Cl-benzenesulfonamide-bearing clinical drug affinities for human carbonic anhydrases
por: Baranauskiene, Lina, et al.
Publicado: (2021)

Structural details of the enzymatic catalysis of carbonic anhydrase II via a mutation of valine to isoleucine
por: Matulis, Daumantas
Publicado: (2020)

RF07 | PSUN356 Synergistic Combination of HSP90 and PI3K inhibitors in Adrenocortical Cancer
por: Mishra, Prachi, et al.
Publicado: (2022)

Boosting the effects of hyperthermia-based anticancer treatments by HSP90 inhibition
por: Vriend, Lianne E.M., et al.
Publicado: (2017)

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1
por: Usmani, Saad Z, et al.
Publicado: (2010)

Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
por: Gillis, Joanna L., et al.
Publicado: (2013)

Antioxidant and Anticancer Activity of Novel Derivatives of 3-[(4-Methoxyphenyl)amino]propanehydrazide
por: Tumosienė, Ingrida, et al.
Publicado: (2020)

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
por: Ye, Min, et al.
Publicado: (2021)

Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
por: Balandis, Benas, et al.
Publicado: (2021)

The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach
por: Spiegelberg, Diana, et al.
Publicado: (2020)

Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors
por: Abdalla, Ashraf N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_brbtjkga0lp53ncjj0qb10nild